Data from a large prospective study identified male and older patients as being more likely to develop CIP and 34% of cases ...
Long-term NATALEE data show adjuvant ribociclib plus an aromatase inhibitor improves invasive disease–free survival vs AI ...
A preliminary analysis of patient-reported outcomes for emotional functioning (EF) in patients with solid tumors revealed ...
The FDA has granted approval to adjuvant cemiplimab treatment for patients with high-risk cutaneous squamous cell carcinoma ...
On this episode of Onc Nurse On Call, Kristin Daly, MSN, ANP-BC, AOCNP, discusses practical cancer care strategies in the age ...
Chemo-induced myelosuppression can affect patients’ ability to do daily tasks, and management varies by patient, treatment ...
Jackson, the administrative director of advanced practice at the Vanderbilt-Ingram Cancer Centers in Franklin and Nashville, ...
A network to connect patients with unused medications with patients in need brought $18 million of free cancer medication ...
Panelists discuss how the subcutaneous nivolumab data demonstrate reassuring safety with minimal grade 3/4 events, how ...
Panelists discuss how the phase 3 MK-3475-877 trial findings demonstrated subcutaneous pembrolizumab’s pharmacokinetic comparability to intravenous (IV) formulation with similar efficacy (45% vs 42% ...